Charles River Laboratories CRL Other Non-Current Liabilities
Other Non-Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.
The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's other non-current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Charles River Laboratories's other non-current liabilities?
- Charles River Laboratories (CRL) reported other non-current liabilities of $510.65M in Q1 2026.
- How has Charles River Laboratories's other non-current liabilities changed year-over-year?
- Charles River Laboratories's other non-current liabilities increased by 160.0% year-over-year, from $196.4M to $510.65M.
- What is the long-term trend for Charles River Laboratories's other non-current liabilities?
- Over 5 years (2020 to 2025), Charles River Laboratories's other non-current liabilities has grown at a -7.6% compound annual growth rate (CAGR), from $205.22M to $138.3M.
- What does other non-current liabilities mean?
- Miscellaneous long-term debts not classified elsewhere.
- How do you interpret other non-current liabilities?
- An increase may signal new long-term commitments or accounting adjustments, while a decrease indicates the settlement or reclassification of these items.
- How does other non-current liabilities compare across companies?
- Varies by company; typically small relative to total liabilities unless specific long-term provisions are required.